उत्पाद विवरण
Dasashil 50 mg Tablet is a targeted anti-cancer therapy featuring dasatinib as its active ingredient, primarily indicated for the treatment of chronic myeloid leukemia (CML), a malignancy characterized by the overproduction of white blood cells. This innovative medication works by inhibiting specific enzymes that promote cancer cell growth, thereby helping to control the progression of the disease and improve patient outcomes. As a prescription-only medication, Dasashil should be used under the supervision of a qualified healthcare professional, who will monitor for potential side effects such as fluid retention, low blood cell counts, or heart-related issues. It is crucial for patients to disclose their complete medical history and any concurrent medications to avoid adverse interactions. Regular blood tests may be required to assess the treatment's effectiveness and manage any complications. With its precise action against CML, Dasashil 50 mg Tablet represents a significant advancement in cancer care, empowering patients in their battle against this challenging condition. Always consult your healthcare provider for tailored advice and guidance regarding your treatment plan.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese